Arcus Biosciences, Inc. — Director's Dealing 2021

Apr 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2021-04-23

Reporting Person: Grossman William (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-23	Common Stock	S	4133	$31.37	Disposed	6717	Direct

Footnotes

F1: Shares sold in a private transaction to Dr. Yasunori Kaneko, a director of Arcus Biosciences, Inc. The shares, representing approximately 1.6% of the total shares either owned or that may be acquired by Dr. Grossman upon exercise of options that are vested and exercisable, were sold by Dr. Grossman as part of his tax plan.